PLAY PODCASTS
Defining and Striving for HBV Cure: What’s in the Pipeline
Episode 179

Defining and Striving for HBV Cure: What’s in the Pipeline

In this podcast, an expert discusses the various definitions/types of HBV cure and different investigational approaches under evaluation for their potential to achieve cure.

Decera Clinical Education Infectious Disease Podcast · Carla Coffin MD MSc

June 30, 202214m 37s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode,  Carla S. Coffin, MD, MSc, shares her thoughts on the different investigational approaches under evaluation for their potential to achieve HBV cure, including entry inhibitors, capsid inhibitors, siRNAs, immune modulators, TLR agonists, therapeutic vaccines, and checkpoint inhibitors.

Presenter:

Carla S. Coffin, MD, MSc
Professor of Medicine
Division of Gastroenterology and Hepatology
Department of Medicine
University of Calgary
Medical Director of Calgary Liver Unit
Division of Gastroenterology and Hepatology
Department of Medicine
Foothills Medical Centre
Calgary, Alberta, Canada

Content based on an online CME program supported by independent educational grants from AbbVie and Gilead Sciences, Inc. and developed in collaboration with the American Liver Foundation. 

Link to full program:
https://bit.ly/3OGHvOv


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

hbv capsid inhibitorshbv functional curehbv therapeutic vaccineshbv treatmenthbv entry inhibitorshbv checkpoint inhibitorsbulevirtidehbv cure definitionshbv sirnahbv cccdnahbv sterilizing cureselgantolimodhbv investigationalhbv nod2 agonistshepatitis b virus investigationalhepatitis b virus cure definitionshepatitis b virus curehbv immune modulatorshbvhbv curehepatitis b virus treatmenthepatitis b virus functional curehbv antisense oligonucleotideshbv tlr agonistshepatitis b virushbv rig-i agonistscarla coffin